A daily, rule-based, multi-asset strategy that uses momentum signals to tilt among levered tech/biotech/foreign themes while maintaining cash buffers and risk hedges to manage drawdowns.

A daily rule-based engine builds a single portfolio from several themed sleeves (e.g., biotech bulls/bears, tech levered, emerging markets, safety/ballast). Each sleeve contains specific assets and is evaluated with momentum indicators (RSI) and price/trend checks over defined windows. Within a sleeve, the strongest assets are chosen (top by moving-average return) and weighted, often using cash-equal rules to keep risk distributed. The engine also uses risk signals (e.g., RSI on volatility proxies like VIXM, current vs moving-average price comparisons, and treasury signals TMF/IEF) to decide when to tilt toward safety or reduce exposure. The result is a daily allocation that seeks growth when momentum is favorable but caps risk with cash buffers and hedges if conditions worsen. Levered ETFs (like TQQQ, LABU, LABD) express directional bets with higher risk, so the risk controls are crucial.

Rule-based, multi-asset momentum strategy tilting to tech/biotech/EM themes with cash buffers and hedges. Out-of-sample return ~19.29% vs SPY ~19.23%; risk controls aim to limit drawdowns while preserving upside—delivering competitive growth with disciplined risk.